chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a nurse (L.P.N.) refers to a patient of unknown age. The patient was vaccinated intradermally with a dose of 0.01 ml PNEUMOVAX23 (lot # not reported) on 01-AUG-2012. The patient was supposed to get purified protein derivative (PPD) as ordered by the physician. The patient is not experiencing any known symptoms. Additional information has been requested.
MOTHER CALLED CLINIC THAT PATIENT HAS RIGHT ARM WHERE VACCINE WAS ADMINISTERED (TDAP) SWOLLEN, RED, AND HOT, AND HAS PAIN FROM SITE TO ELBOW, AND REFERS HE CANNOT MOVE ARM MUCH. SHE TOOK HIM TO THE EMERGENCY ROOM, WHERE THE DOCTOR REFERRED THAT IT WAS AN ADVERSE EFFECT, THEY ADMINISTERED ANTIBIOTICS AND ANTIINFLAMMATORY MEDICATION IV FOR TWO DAYS. ON 1/23/2017 I CALLED TO FOLLOW UP ON PATIENT AND MOTHER REFERS TO SEE HIM MUCH BETTER, WITH MOVEMENT, AND NO PAIN, STILL ON MEDICATION PRESCRIBED BY DOCTOR. SHE REFERS THAT SHE WILL NO LONGER BE VACCINATING CHILD SINCE HE STATES THAT HE NO LONGERS WANTS TO RECEIVE VACCINES. I ORIENTATED MOTHER AND EXPLAINED THE IMPORTANCE TO VACCINATE PATIENT.
injection site soreness; headache; fatigue; who is 30 weeks pregnant/ administered GARDASIL 9; was expected to receive TDap, but was administered GARDASIL 9 instead; This spontaneous report has been received from a registered nurse, concerning her granddaughter a 31-year-old female patient who was pregnant with 30 weeks at the time of report. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported.  On 15-JUN-2022, the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 0.5 ml, intramuscular (lot #, expiration date and anatomical location were not provided) as prophylaxis, instead of a dose of diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) in her provider's office (exposure during pregnancy, wrong vaccine administered). On the same date, she experienced fatigue, injection site soreness (vaccination site pain) and headache. The outcome for the events of fatigue, vaccination site pain and headache was not reported.  The causality assessment between hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for fatigue, vaccination site pain and headache was not reported.  At the reporting time, the outcome of the pregnancy was unknown.
Developed a 3" diameter swollen, red. warm, area with orange peel appearance at injection site.  Mild pain and itching to site. It is 2 days later and symptoms have not changed much.
Moderna vaccine was given to a 15 year old patient. The parent requested Moderna specifically and the age was not reviewed right before vaccination. Error was caught when looking at the clinic schedule for 2nd doses. Patient's parent contacted, informed, and patient finished the immunization schedule with Pfizer. No harm documented.
Headache, severe night sweats, fever. Diagnosed Multisystem inflammatory syndrome based on pericardial effusion, pleural effusions, myocarditis (a. fib). and arthritis. Pericardial window with biosy and bilateral thoracentesis done. Multiple medications started, including high dose prednisone, leading to steroid myositis, fascial shingles, and opportunistic infection with presumed nocardia (lung and brain). Total 6 hospitalizations (39 nights). Recent partial, sensory seizure from residual frontal lobe abscess. Multiple COVID rapid, PCR and antibody tests from 9/10/2020 to 8/30/2021 have all been negative. Vaccine generated antibodies high at 225 on 8/30/2021.
Vial was initially stored in the refrigerator on 14-Jan-2023/Vaccine administered on 27-Feb-2023; No adverse event; patients had Moderna beyond the 30-day BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients had Moderna beyond the 30-day BUD), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 14-Jan-2023/Vaccine administered on 27-Feb-2023) and NO ADVERSE EVENT (No adverse event) in a 54-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 016H22A) for COVID-19 prophylaxis.     No Medical History information was reported.  On 27-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Feb-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (patients had Moderna beyond the 30-day BUD). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 14-Jan-2023/Vaccine administered on 27-Feb-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients had Moderna beyond the 30-day BUD), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 14-Jan-2023/Vaccine administered on 27-Feb-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patients had Moderna beyond the 30-day BUD) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 14-Jan-2023/Vaccine administered on 27-Feb-2023).    No concomitant medications were reported.  It was unknown if the patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Vial size was 2.5 ml The vial was initially stored in the refrigerator 14-Jan-2023.  The vial did not undergo any temperature excursions.  No treatment medications were reported.  This case contains information for the 3 of 3 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-716944, US-MODERNATX, INC.-MOD-2023-716921, US-MODERNATX, INC.-MOD-2023-716921 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716944:Patient 2
pt had an intussusception which could note be reduced w/ air contrast enema & required surgery;hosp
Nearly fainted. Vision turned black, hearing became very muffled, and blood pressure dropped significantly. I lied down on the table and rested until everything returned to normal.
03/23/2021 - injection given and within 2-3 minutes after injection I had heart palpitations and flush of heat over my body. After about 3 minutes heartbeat regulated and flush of heat dissipated. About 45 minutes later I got a headache last about 15 minutes.  Then came back about an hour later lasting same time before stopping. This occurred again about 3 hours later, same as before.  03/24/2021 - arm was sore and injection site was slightly itchy and hot but stopped by 03/25/2021, no hunger. 03/24/2021 - woke up feeling nauseous and overall crappy feeling (not achy, not in pain). nausea lasted throughout the day, but no vomiting. headache often throughout the day but not lasting more than 10-15 minutes, no hunger. 03/25/2021 - again woke up feeling nauseous lasting off/on thru day, no vomiting, no headache, feeling overall more energetic wanting to eat when nausea went away. 03/26/2021 - woke up NO nausea, not hungry so ate later in afternoon. Within 20 minutes of me eating I became extremely fatigued, dizzy and could barely stand up. I started to feel like I was going to faint and got to a couch and laid down. I started sweating and felt like my body was on fire. My scalp and face were wet with sweat, I felt dizzy and extremely nauseous before I vomited (3) times. After vomiting the dizziness, nausea and weakness dissipated. After about 30 minutes I just felt tired and my chest hurt from the convulsions of vomiting.  After about 2 hours I felt better and just tired. 03/27/2021 - woke up no nausea, no headache and slightly fatigued.
02/4/02-DTaP, HIB, MMR, varicella, given at approximately 2:15. At approximately 3 pm on 2-4-02. Mother returned with child, child had facial, swelling ears swollen redness on face and ears also noted. No difficulty breathing or rash noted. 10 mg Decadron given IM as well as 7 cc of Benadryl po Child observed for approximately 1 hour . Facial redness and swelling had decreased, discharged per the child's pediatrician. Verbal inst. to continue with oral Benadryl every 4 to 6 hours, 7 ml x 24 hours, telephone call on 2/5/02 to mother , states child continues to improve.
After the shot I was very tired, sluggish, and low energy. It lasted about a week. I switched to the Pfizer vaccine for my last booster and had no side effects. I also had COVID-19. I was tired. I went to sleep a lot. It lasted for two months. My doctor gave me an inhaler and told me to rest and drink liquids.
Vague chest tightness and tickle in her throat.  .Improved with albuterol treatment.  Hx of nausea with PEG - no anaphylaxis with PEG.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On an unknown date in 2015 (reported as "between 01-SEP-2015 and 09-OCT-2015"), the patients received an unspecified doses in the immunization series of PROQUAD (Merck) (lot # L019994, expiration date 02-DEC-2016) (dose and route of administration were not reported) that were improperly stored. No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Rt. side facial droop - MRI brain (small focus abnormal T2 signal (L) insular cortex); carotid US was negative; CT negative. Dx'd with Bell's Palsy.
Client had influenza vaccine 10/11/03. Rash reported 10/12/03 at 9AM. Client also on TMP/SMX since 10/2/03. D.C. TPM/smx, give benadryl 50mg IM Stat and 25mg p.o. qidx 2 days. Rash reported as scattered wheal like to both arms, buttocks, back, both thighs. Wheals raised, red uneven borders, various sizes. No rash 10/19/03.
Paralysis of right arm and both legs, onset 9/5/13 after minor tumble. MRI spine revealed edema/myelitis C2-C7, 9/6/13, MRI normalized 9/12/13 after high dose steroids.
second dose to a patient that was past 24 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (second dose to a patient that was past 24 hours) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (second dose to a patient that was past 24 hours). On 13-Jul-2021, EXPIRED PRODUCT ADMINISTERED (second dose to a patient that was past 24 hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Pinpoint rash dots on left arm. Joint pain (patient has arthritis could be from that) not sure if it is from vaccine.
Patient indicates she has had balding and thinning hair since she received a second ZOSTAVAX shot 5/1/13 after receiving the first shot 1/13/2011. She says it has progressively gotten worse.
I?m always an optimistic person but about 5 days from receiving the first and second dose I experienced severe depression and thoughts of suicide which I recognized as unusual yet I couldn?t help feeling so hopeless and depressed for about two weeks after each shot. I feel a bit better now but I have also noticed this depression in my kids who have received the shot as well. We have no other stressors or issues going on other than having had the shot.
On Evening of 11/17/2020 Pt had Fever @ home oF 106 degrees Axillary. Went to ER. Temp There 104 degrees (R). Pt observed + discharged. Fever For about 48 hours post immunizations.
Patient received Pfizer vaccine on 02/24/21, 03/24/21, and 11/3/21. Presented to ER on 1/10/22 and was admitted for 19 hours. COVID positive 1/2/22. Onset of symptoms started after being diagnosed with COVID-19 on 01/02. He has been evaluated in the emergency department multiple times for dehydration as requested by his primary care doctor Dr. He states that despite following his recommendations he has not improved. He reports a weight loss of almost 20 lb. He feels as if he can no longer take care of himself with his progressively declining health. Was discharged with no further COVID19 treatments.
1) fever up to 101 F for 48 hours on 02/03//2021 and 02/04/2021 2) fatigue from 02/03/2021 until now 06/17/2021 3) dizziness from  02/03/2021 until now 06/17/2021 4) heart-pounding/palpitations from 02/03/2021 until now 06/17/2021, occurs more frequently from April 04/14/2021 until 06/17/2021. caused faint if have persistent heat pounding 5) loss balance while walking 6) wake up due to palpitations on 06/09/2021 from 02:00 AM, and couldn't back to sleep  7) shorten of breath if using stairs over 15 steps 8) shorten of breath if the sidewalk is uphill 9) lost appetite
Pt experienced swelling at the injection site. It occurred about 10 minutes after the shot and pt stated the swelling was the size of a small egg. Pt iced the area and swelling went down.
This is a 28 year old male Caucasian who was in his usual state of health until 05/22/04, 8 days following his primary smallpox and 15 days following his 6th anthrax vaccination. On 5/22/04 the client relates that he developed episodic nausea and dizziness. He denies any fever, chills, vomiting, diarrhea, constipation, chest pain or dyspnea. He states that these symptoms were transient and last only a day or two.  On 05/26/04, 12 days following his primary smallpox vaccination and 19 days following his anthrax vaccination, the client reports that he noted upon waking, a bright red rash on his bilateral arms, legs, torso and to a lesser extent his face. He reported to the immunization clinic and was referred to the Vaccine Healthcare Center (VHC) for further evaluation. The client stated  that as the day progressed his rash became lighter and lighter, and itched less.   He presented to the VHC at approximately 1430 hours and was evaluated.  At that time, his raise was barely visible and spotty on his arms and two or three probable lesions on his back. He stated that he thought maybe it was going to go away. The possibility of this presentation being a non-viral pustulosis was discussed with the client and his spouse. He and his family were reassured that this was not a contagious condition, which was there main concern. He was prescribed Benadryl® 25-50mg q 6 hours PRN itching and Motrin® 600mg po TID PRN for discomfort and anti-inflammatory properties of the medication.   On 05/27/04, the client's spouse notified the VHC that the client had been seen in the emergency department the previous evening for reoccurrence of his rash and severe itching. The client's spouse stated, "the rash had severe whelping, like poison ivy". The client reportedly was given Zantac® in addition to the Benadryl® and placed sick in quarters for the remainder of the night. The client was still sleeping when the spouse called and the NP was unable to speak with him at that time.
received Moderna for two doses and received the Pfizer; This is a spontaneous report received from a contactable reporter (Nurse) from medical information team, Program ID: (RA).  A 2-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Jan2023 as dose 3 (maroon cap), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna covid-19 vaccine (DOSE 1, SINGLE), for Covid-19 Immunization; Moderna covid-19 vaccine (DOSE 2, SINGLE), for Covid-19 Immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 18Jan2023, outcome "unknown", described as "received Moderna for two doses and received the Pfizer".  Follow-up attempts are completed. No further information is expected.
Information has been received from a physician concerning a male who on 13-SEP-2007 was vaccinated subcutaneous with "1 vial" of varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck) (MSD). The patient sought medial attention via an office visit. No diagnostic labs were performed. No adverse reaction observed. A product quality complaint was not involved. Additional information has been requested.
The child recieved Pentacel and Prevnar and within 5 minutes of recieving the vaccines he developed a diffuse urticaria and vomiting.
No additional AE reported; the patients that were administered the vaccines involved in the temperature excursion; This spontaneous report has been received from a pediatric office clinical coordinator, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant medications were not reported.   On 10-AUG-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (dose, vaccination scheme, route of administration and anatomical site of vaccination were not reported; lot number T032930 has been verified to be a valid lot number, expiration date reported and established as 28-SEP-2022) as prophylaxis.   The vaccine was exposed to a temperature excursion of 15.7 degrees Fahrenheit (F) during a time frame of 35 minutes; with no previous temperature excursion. No additional adverse events reported.  This is one of multiple reports received from the same reporter.; Sender's Comments:  US-009507513-2108USA004580: US-009507513-2108USA003330: US-009507513-2108USA004582:
Fever of 100-102 starting from 12 hours after vaccine, lasting for 12 hours.
Aches and pains; Muscle tightness; This case was reported by a consumer via call center representative and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced pain and muscle tightness. On an unknown date, the outcome of the pain and muscle tightness were unknown.   It was unknown if the reporter considered the pain and muscle tightness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The patient experienced side effects like aches and pains muscle tightness. The patient asked, how long do the side effects last with the shingles vaccine. The reporter did not consent to follow up.
Felt a little bit heaviness; Little bit bone ache; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administration date 07Jan2021 (Lot number: EL3248) at the age of 68 years as dose 2, single and administered in arm left, administration date 21Dec2020 09:00 (Lot number: EJ168) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Insomnia" (unspecified if ongoing), notes: Verbatim: Insomnia. The patient's concomitant medications were not reported. The following information was reported: HEAD DISCOMFORT (non-serious), outcome "unknown", described as "Felt a little bit heaviness"; BONE PAIN (non-serious), outcome "unknown", described as "Little bit bone ache". Therapeutic measures were not taken as a result of head discomfort, bone pain.  Additional information: it was reported got my vaccine was doing just fine, lately she feel like a little bit heaviness, a little bit bone ache, a little bit, not just 'drive' by herself and about 2 weeks ago she received a case for one of her friend saying that the people that have Pfizer they did their body get magnet and feeling that they can attract magnet. she ignored that she said no this is not true and did not pay attention to that. Today one of doctor claim that his body has like metal 'attracting' electricity magnet and she thought let me trying on herself and see if its having the pain or may be something has wrong and she put some screw on her chest and arm and none of them is dropping down and his magnet attaching to her skin. Vaccination facility: Hospital. No other vaccine within 4 weeks.   No follow-up attempts are possible. No further information is expected.
Rt upper arm with 80mm redness, firmness, mod swelling, afebrile c/o body aches
PT COMPLAINED OF SORE/ DRY THROAT - STARTED 30 MINUTES TO AN HOUR AFTER VACCINE
Headache, soreness of arm, face flushed, arm swelled, and as evening wore on pain in arm grew greater and greater with every passing hour - could not move arm without experiencing very bad pain that encompassed several days' time.
arm hardly hurt; This is a spontaneous report from a female contactable consumer (patient) reported for herself. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient experienced arm hardly hurt (non-serious) on an unspecified date with outcome of unknown. Caller stated that she had the second dose about 16 days ago and really didn't have any symptoms at all. Caller stated that her arm hardly hurt.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
PT CAME TO THE PHARMACY A FEW DAYS LATER AFTER ADMINISTRATION OF PREVNAR SHOT WITH SORE ARM AND SWOLLEN.
Itchy at injection site that has lasted several days off and on. A small rash has formed after scratching the area
Continued Chest tightness, tightness in the middle of my shoulder blades on my back, terrible headache for the better part of 2 weeks.  Feelings of anxiety like my heart races in waves.
reactive arthritis/inflammatory arthritis that lasted 3 months. Responded to course of steroids
It was reported that on approx 11DEC89 pt was administered rubella virus vax live; subsequently, pt became totally & permanently deaf;
21SEp rash on neck, progressed to face & trunk; 24SEP rash resolved; 27SEP painful swelling in fingers & hands, some relief w/Indocin-duration @ least 4 wks;